|
||||||
| Home |
| Find a Clinical Trial |
| Clinical Trial FAQs |
| About Informed Consent |
| Clinical Trials Glossary |
| Medical Research Areas |
| Clinical Trial Resources |
|
 |
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only. | |
|
|
 |
|
|
|
|||
|
Novartis Clinical
Trials provides information about research studies recruiting
within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S. |
|
|
Find a Clinical Trial
Kidney Cancer (Renal Cell Carcinoma) Study - L2202An open-label, multicenter phase II study to compare the efficacy and safety of a Novartis investigational drug as first-line followed by second-line approved therapy versus the approved therapy as first-line followed by a second-line Novartis investigational drug in the treatment of patients with metastatic renal cell carcinoma. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.
Trial phase: Phase 2 Participation Duration: Participants will be required to visit the study center 2 times during each 42 day treatment cycle. Participation duration will last until disease progression, unacceptable toxicity, or discontinuation from treatment for any other reason. Protocol Number: CRAD001L2202 The next step is to see if you (or the participant) meet the basic criteria required for participation in this clinical trial. Please fill out the questionnaire below to see if you (or the participant) may be suitable for the clinical trial. Your answers to these questions are not retained by this system. You must answer the questions below for yourself, or, you must be the legally authorized representative of the potential participant in order to answer the questions on their behalf. If you (or the participant) do not meet the preliminary qualifications, you may search for other clinical trials of interest or sign up to the Mailing List. Answers to all questions are required to determine if you meet the preliminary qualifications for the study.
|